Traditional antibiotics like penicillin may now be powerless against new strains of bacteria, but now doctors are looking to a new class of drugs to do the trick.
"She's a true little girl, but yet she doesn't let her tomboy older sister and little brother go off without her."
So when this bundle of energy struggled to breathe, John and Twana knew something was wrong.
"It was very scary, very, very scary. They're like, 'No, don't leave her at all in this room by herself, even to go to the bathroom," says Twana Krauhs, Amy’s mom.
Amy had pneumonia from an antibiotic-resistant bacteria. Doctors turned to a new medication.
"It's the first new class of antibiotics that's been approved for use by the FDA in perhaps 10 years or so," says Dr. Sheldon L. Kaplan.
Studies show linezolid is as effective as gold standard medications but works on a different site on the bacteria, making it effective against antibiotic-resistant bacteria. Dr. Kaplan says as antibiotics are used unnecessarily, bacteria build up a resistance to drugs.
"We need newer antibiotics to address these resistance problems, which I think are just going to continue to increase."
Twana is thankful the medication worked when Amy needed it.
"She's too young, too valuable a little life to take that chance on."
For more information, contact:
Director of Communications
Baylor College of Medicine
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.